Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $300.98 +1.78%
EPS Growth %: -30.7%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
DBVT, FNGR, SFNC, More
EPS Growth %: -30.7%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
DBVT, FNGR, SFNC, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.09, $0.14 better than the analyst estimate of $0.95. Revenue for the quarter came in at $536.8 million versus the consensus estimate of $537.58 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon to cut 3,000 jobs as it shifts stores to franchises
- Wipro (WIT) Misses Q2 EPS by 1c
- Kepler Cheuvreux Upgrades Interroll Holding AG (INRN:SW) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
